Rifampicin as monotherapy for infections caused by Staphylococcus aureus: considerations for not applying

Sara E Boyd1,2,3, Mandy Wootton4, Robin A Howe4

  • 1David Price Evans Global Health and Infectious Disease Research Group, University of Liverpool, Institute of Systems, Molecular & Integrative Biology, William Henry Duncan Building, Liverpool L7 8TX, UK.